Dr Pappas is a Professor of Medicine in the Division of Infectious Diseases and Tinsley Harrison Clinical Scholar, Department of Medicine at the University of Alabama in Birmingham. Dr Pappas attended medical school at the University of Alabama at Birmingham, graduating in 1978. He completed his residency in internal medicine, chief medical residency, and infectious diseases fellowship at the University of Washington in Seattle.
Following completion of his fellowship, he was on the clinical faculty at the University of North Carolina School of Medicine in Chapel Hill, NC, through its affiliated hospital in Wilmington, North Carolina. In 1988, he joined the faculty at the University of Alabama in Birmingham School of Medicine, with a focus on HIV and transplant-associated opportunistic infections, especially the invasive mycoses.
His main areas of interest have included the development of new therapies for fungal infections and understanding the epidemiology of candidiasis, the endemic mycoses, and cryptococcosis. He has performed a number of clinical trials in candidiasis, cryptococcosis, aspergillosis, sporotrichosis, blastomycosis, and histoplasmosis through his involvement with the NIAID BAMSG.
He is the Principal Investigator for the Mycoses Study Group, a group that will continue to perform multicenter trials, create treatment guidelines for invasive mycoses, and coordinate CME training in the epidemiology, diagnosis and treatment of invasive mycoses. He is also the PI of a national network of transplant centers, TRANSNET, in conjunction with CDC and a consortium of industry co-sponsors to provide important epidemiologic and treatment information to transplant recipients who develop proven and probable invasive fungal infections. Finally, he is co-PI of the Organ Transplant Infection Detection and Prevention Program (OTIP), a collaborative multicenter group funded by CDC.
David Andes is Professor of Medicine at the University of Wisconsin, and Head of the Division of Infectious Diseases there. He completed medical school at University of Missouri, Columbia and his internal medicine residency training at the University of Wisconsin, where he served as Chief Resident. He completed his infectious disease fellowship at the University of Wisconsin as well as post-doctoral research training in molecular biology/mycology under the mentorship of Bernard Weisblum and Bruce Klein followed by studies of molecular mycology at the Marine Biological Laboratory at Wood’s Hole. He is editor of Antimicrobial Agents and Chemotherapy, Mayo Clinic Proceedings, PLoS One and on the editorial boards of Journal of Infectious Diseases, Eukaryotic Cell, Faculty of 1000, Diagnostic Microbiology and Infectious Diseases, Virulence, Medical Mycology, Pharmaceutics, and Frontiers in Mycology.
Oliver Cornely is Professor of Internal Medicine and Attending Physician at the 1st Department of Internal Medicine, and Medical Director of the Center of Clinical Trials (ZKS) at the Medical Faculty, both located at the Uniklinik Köln, Cologne, Germany. Dr. Cornely received his medical degree from the University Hospital at Albertus Magnus University, Cologne, in 1994, where he also completed his residency. He then became an intern at the St. Katharinen Hospital, Frechen, Germany. He passed the Board Examinations in internal medicine, infectious diseases, haematology/oncology, and emergency medicine. Originating from an HIV/AIDS clinical research group, Dr. Cornely’s research interests include invasive fungal diseases in haematology/oncology and in the ICU setting. Dr Cornely is also a clinical infectious diseases consultant at the University Hospital of Cologne. Dr Cornely was recently elected President of the European Confederation of Medical Mycology for a 3-year term. He is past-President of the German-speaking Mycological Society, reviewer for numerous international journals, editorial board member for international journals such as Haematologica, Infectious Disease and Clinical Investigation, Editor in Chief of Mycoses, and a sought after invited speaker at numerous international and national conferences and popular workshop leader.